Most countries that regulate the term gluten-free have converged on a common limit: less than 20 milligrams of gluten per kilogram of food. The Codex Alimentarius Commission at the Food and Agriculture Organization and World Health Organization recommends this value, and the U.S. Food and Drug Administration and the European Commission implement similar thresholds for packaged foods. This shared benchmark improves international reliability, but real-world accuracy depends on testing methods, supply-chain practices, and regulatory enforcement.
Causes of variability
Manufacturing processes create the main source of inconsistency. Shared facilities, common milling equipment, and bulk transport can introduce cross-contact between gluten-containing and gluten-free ingredients. Analytical methods differ in sensitivity: commonly used enzyme-linked immunosorbent assays detect intact gluten proteins but may underreport fragmented or processed gluten. Small producers and informal markets are less likely to use validated testing or strict separation, so labeled claims from those sources are more variable. Massimo Catassi at Università Politecnica delle Marche has published on the clinical relevance of very low gluten intakes, underscoring why measurement limits matter for people with celiac disease.
Regulatory frameworks and enforcement intensity also vary. Some jurisdictions require literal compliance and permit enforcement actions when a product exceeds the threshold, while others have voluntary labeling with minimal oversight. Third-party certification programs add an extra layer of verification, but certification standards and audit rigor differ from one organization to another.
Consequences for consumers and environments
For people with celiac disease, even small amounts of gluten can cause intestinal damage or symptoms over time. Alessio Fasano at Massachusetts General Hospital and Harvard Medical School has characterized celiac disease as an autoimmune process triggered by gluten ingestion, which explains why consistent labeling and accurate testing are clinically important. For those with non-celiac gluten sensitivity the risk is less well quantified, but unreliable labels still create dietary uncertainty and social burden.
Cultural and territorial factors shape exposure and trust. In regions where staple grains are wheat-based and food systems are informal, reliance on packaged gluten-free labels is lower and homemade or traditional substitutions are more common. In export-driven markets, harmonized standards facilitate cross-border trade but may exclude small artisanal producers who cannot afford testing. Environmentally, crop rotation, volunteer grains, and equipment shared between cereal crops can lead to field-level contamination that ultimately impacts the gluten content of supposedly gluten-free grains.
Practical implications are clear: an internationally harmonized 20 mg/kg threshold improves baseline reliability, but label accuracy is not guaranteed everywhere. Consumers most at risk are best served by choosing products from manufacturers with transparent testing, looking for reputable third-party certification, and being aware of local market differences. Regulators and industry can further improve reliability through standardized, validated testing for processed foods, stronger enforcement in weaker jurisdictions, and investment in segregated supply chains to reduce cross-contact. These measures address both the scientific measurement challenges and the human need for safe, trustworthy food.